FIELD: pharmacology.
SUBSTANCE: invention is a combined drug of anxiolytic, stress-protective, nootropic and antioxidant action containing tryptophan, characterised by additional content of tiotriazoline at a quantitative ratio: tryptophan ranging from 1 to 7 wt parts per 1 wt part of thiotriazoline.
EFFECT: agent has a higher anxiolytic and antioxidant activity compared to the known agents and has additional nootropic and stress-protective action.
3 cl, 5 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTICONVULSANT MEDICAL PRODUCT | 2007 |
|
RU2361591C1 |
| MEANS FOR CORRECTION OF PSYCHOEMOTICAL STATUS OF ORGANISM BASED ON ASTRAGALUS HERBS EXTRACT | 2016 |
|
RU2642595C1 |
| ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
| CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
| COMBINED DRUG FOR PHARMACORRECTION OF COGNITIVE DYSFUNCTIONS AFTER KETAMINE ANESTHESIA | 2020 |
|
RU2748035C1 |
| HEPATOPROTECTIVE, CARDIOPROTECTIVE AND PLACENTAPROTECTIVE, UTEROLITH AND NO-MIMETIC COMBINED DRUG | 2015 |
|
RU2597785C1 |
| LYSINIUM 3-METHYL-1,2,4-TRIASOLYL-5-THIOACETATE WITH NEUROPROTECTIVE, NOOTROPIC, CARDIOPROTECTIVE, ENDOTHELIOTROPIC, ANTI-ISCHEMIC, ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTIHYPOXIC EFFECT AND LOW TOXICITY | 2007 |
|
RU2370492C2 |
| CEREBROPROTECTIVE AND NOOTROPIC MEDICINAL AGENT "NOOTRIL" IN ENVELOPE-COVERED TABLET | 2003 |
|
RU2248203C2 |
| COMBINED DRUG FOR PRIMARY NEUROPROTECTION | 2017 |
|
RU2636616C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
